Enter a Search String |
| Special character and space not allowed in the query term. Search string should be at least 2 characters long. |
Molecule List for pathway EGFR (Pathway Number 223)
| Name | Initial Conc. (uM) td> | Volume (fL) | Buffered | ||
| 1 | EGF | 0.666 | 1.6667E-6 | No | |
| Taken from Kholodenko et al 1999 Simulations were done at EGF concentration set to 20nM and 2nM concentration. This concentration was multiplied by a constant factor Vm/Vcw = 33.3 to formally rescale it to the cytoplasmic water volume. So actual concentration to which EGF was set was 666nM and 66.6nM. Plots 1&3 of figure-5 and plot 1 of figure 4 are obtained by setting the EGF conc to 666nM. Plots 2&4 of figure-5 and plot 3 of figure 4 are obtained by setting the EGF conc to 66.6nM. | |||||
| 2 | enz16 | 0.001 | 1.6667E-6 | No | |
| Taken from Kholodenko et al 1999. | |||||
| 3 | enz4 | 0.001 | 1.6667E-6 | No | |
| The initial concentration was set to 1nM. Citation: Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 4 | enz8 | 0.001 | 1.6667E-6 | No | |
| The initial concentration was set to 1nM. Citation: Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 5 | G-S | 0.033 | 1.6667E-6 | No | |
| Personal communication: Dr.Boris N. Kholodenko Citation: Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 6 | Grb | 0.052 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. To obtain plots as per figure-4 and 5 [Grb] is set to 51.954nM. instead of 85nM. Thanks to Dr. Boris N. Kholodenko for clarifying the ambiguity and furnishing us the above value. To obtain plots as per figure-7A [Grb] is set to 340nM (4-fold increase). | |||||
| 7 | Grb2_Shc | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. Total concentration of Grb2 bound to Shc isoforms= [Sh-G-S] [R-Sh-G] +[R-Sh-G-S] + [Sh-G] | |||||
| 8 | Grb_EGFR | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. Total concentration of Grb2 bound to EGFR forms = [R-G] + [R-G-S] + [R-Sh-G] + [R-Sh-G-S] | |||||
| 9 | pEGFRtot | 0 | 8.3335E-7 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. Total phosphorylated EGFR = 2.([RP] + [R-PL] + [R-PLP] + [R-G] + [R-G-S] + [R-Sh] + [R-ShP] + [R-Sh-G] + [R-Sh-G-S] ) | |||||
| 10 | PLCr | 0.105 | 1.6667E-6 | No | |
| PLC gamma. Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 11 | PLCr-I | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 12 | PLCrP | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 13 | pPLCr | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. Total Phosphorylated PLCr = [R-PLP] + [PLCrP]. | |||||
| 14 | pShctot | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. Total phosphorylated Shc = [ShP] + [Sh-G] + [ Sh-G-S] + [R-ShP] [R-Sh-G] + [R-Sh-G-S] | |||||
| 15 | R | 0.1 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. [EGFR] = 100nM. To obtain the plots as per figure-7B [EGFR] was increased 4-fold (400nM) to obtain plot-1 and decreased 4-fold (25nM) to obtain plot-2. | |||||
| 16 | R-G | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 17 | R-G-S | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 18 | R-PL | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 19 | R-PLP | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 20 | R-Sh | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 21 | R-Sh-G | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 22 | R-Sh-G-S | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 23 | R-ShP | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 24 | R2 | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 25 | Ra | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 26 | RP | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 27 | Sh-G | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 28 | Sh-G-S | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 29 | Shc | 0.15 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. To get plots in figure-4 and figure-5 [Shc] is set to 150nM To get plots in figure-7A [Shc] is set to 37.5nM (4-fold decrease). | |||||
| 30 | Shc_EGFR | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. Shc bound to EGFR = [R-ShP] + [ R-Sh-G] + [R-Sh-G-S] | |||||
| 31 | ShP | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. | |||||
| 32 | SOS | 0.001 | 1.6667E-6 | No | |
| The initial concentration is set to 0.95421nM instead of 37nM which. Thanks to Dr. Boris N. Kholodenko for clarifying the ambiguity and furnishing the initial concentration. | |||||
| 33 | SOS_EGFR | 0 | 1.6667E-6 | No | |
| Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. Total Sos bound to EGFR = [R-G-S] + [R-Sh-G-S] | |||||
Summed Molecule List
|   | Target | Inputs |
| 1 | Grb2_Shc | R-Sh-G Sh-G R-Sh-G-S Sh-G-S | Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. Total concentration of Grb2 bound to Shc isoforms= [Sh-G-S] [R-Sh-G] +[R-Sh-G-S] + [Sh-G] |
| 2 | Grb_EGFR | R-G R-G-S R-Sh-G R-Sh-G-S | Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. Total concentration of Grb2 bound to EGFR forms = [R-G] + [R-G-S] + [R-Sh-G] + [R-Sh-G-S] |
| 3 | pEGFRtot | RP R-PL R-PLP R-G R-G-S R-Sh R-ShP R-Sh-G R-Sh-G-S | Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. Total phosphorylated EGFR = 2.([RP] + [R-PL] + [R-PLP] + [R-G] + [R-G-S] + [R-Sh] + [R-ShP] + [R-Sh-G] + [R-Sh-G-S] ) |
| 4 | pPLCr | R-PLP PLCrP | Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. Total Phosphorylated PLCr = [R-PLP] + [PLCrP]. |
| 5 | pShctot | R-ShP R-Sh-G R-Sh-G-S ShP Sh-G Sh-G-S | Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. Total phosphorylated Shc = [ShP] + [Sh-G] + [ Sh-G-S] + [R-ShP] [R-Sh-G] + [R-Sh-G-S] |
| 6 | Shc_EGFR | R-ShP R-Sh-G R-Sh-G-S | Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. Shc bound to EGFR = [R-ShP] + [ R-Sh-G] + [R-Sh-G-S] |
| 7 | SOS_EGFR | R-G-S R-Sh-G-S | Taken from Kholodenko BN et al J Biol Chem. (1999) 274(42):30169-81. Total Sos bound to EGFR = [R-G-S] + [R-Sh-G-S] |
| Pathway Detail | Molecule List | Enzyme List | Reaction List |